microtubule
Vinflunine (0.01-10 μM; 45 min) induces a rapid change in endothelial cell shape: cells retracted and assumed a rounded morphology.
Vinflunine (0.01-10 μM; 1 h) disrupts newly formed capillary-like structures.
Vinflunine (0.01-10 μM; 1 h) inhibits endothelial cell motility, with an IC
50
of 0.71 μM.
Vinflunine (0.001-10 μM; 1-72 h) inhibits endothelial cell proliferation in vitro.
Vinflunine (0.08-20 mg/kg; i.v.) reduces the number of experimental liver metastases by human LS174T colon cancer cells.
Vinflunine (0.63-5 mg/kg; i.v. before and 2 d after Matrigel implantation) inhibits the bFGF-induced angiogenic response in mice in a dose-dependent manner.
| Animal Model: | Female athymic nude mice (BALB/c/Ola/Hsd-nu) were implanted LS174T cells |
| Dosage: | 0.08, 0.16, 1.25, 5, 10, 20 mg/kg |
| Administration: | I.v. on days 4, 7, 11, 14, 18 and 21 after tumour cell implantation |
| Result: | Induced a dose-dependent reduction in the number of metastatic foci at the surface of the liver and was well tolerated. |